179 related articles for article (PubMed ID: 37845358)
1. PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer.
Ding N; Li M; Zhao X
Sci Rep; 2023 Oct; 13(1):17521. PubMed ID: 37845358
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.
Wang Z; Yang X; Liu C; Li X; Zhang B; Wang B; Zhang Y; Song C; Zhang T; Liu M; Liu B; Ren M; Jiang H; Zou J; Liu X; Zhang H; Zhu WG; Yin Y; Zhang Z; Gu W; Luo J
Mol Cell; 2019 Jun; 74(6):1250-1263.e6. PubMed ID: 31054974
[TBL] [Abstract][Full Text] [Related]
3. PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.
Mao S; Li Y; Lu Z; Che Y; Huang J; Lei Y; Wang Y; Liu C; Wang X; Zheng S; Sun N; He J
Cancer Med; 2019 May; 8(5):2429-2441. PubMed ID: 30932358
[TBL] [Abstract][Full Text] [Related]
4. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma.
Yang Y; Zhu J; Zhang T; Liu J; Li Y; Zhu Y; Xu L; Wang R; Su F; Ou Y; Wu Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):65. PubMed ID: 29566713
[TBL] [Abstract][Full Text] [Related]
5. Plant homeodomain-finger protein 5A: A key player in cancer progression.
Diaba-Nuhoho P
Biomed Pharmacother; 2023 Dec; 169():115857. PubMed ID: 37951028
[TBL] [Abstract][Full Text] [Related]
6. Research progress and therapeutic prospect of PHF5A acting as a new target for malignant tumors.
Li M; Cheng Q; Wang X; Yang Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):647-655. PubMed ID: 36581580
[TBL] [Abstract][Full Text] [Related]
7. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract][Full Text] [Related]
8. PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS.
Zhang Z; Peng L; Yang W; Li B; Hua Y; Luo S
J Transl Med; 2023 Jan; 21(1):5. PubMed ID: 36609277
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker.
He Z; Song B; Zhu M; Liu J
Sci Rep; 2023 Mar; 13(1):5069. PubMed ID: 36977736
[TBL] [Abstract][Full Text] [Related]
10. PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation.
Liu C; Li G; Zheng S; She L; Lu S; Wang Y; Huang D; Zhang X; Sun L; Liu Y; Qiu Y
Biol Direct; 2023 Jul; 18(1):39. PubMed ID: 37434235
[TBL] [Abstract][Full Text] [Related]
11.
Yang Y; Li M; Zhou X; Wang W; Shao Y; Yao J; Wang X
Ann Clin Lab Sci; 2022 May; 52(3):439-451. PubMed ID: 35777798
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.
Hubert CG; Bradley RK; Ding Y; Toledo CM; Herman J; Skutt-Kakaria K; Girard EJ; Davison J; Berndt J; Corrin P; Hardcastle J; Basom R; Delrow JJ; Webb T; Pollard SM; Lee J; Olson JM; Paddison PJ
Genes Dev; 2013 May; 27(9):1032-45. PubMed ID: 23651857
[TBL] [Abstract][Full Text] [Related]
13. [PHF5A Promotes Proliferation and Migration of Non-Small Cell Lung Cancer
by Regulating of PI3K/AKT Pathway].
Wang H; Liu F; Bai C; Xu N
Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):10-16. PubMed ID: 36792075
[TBL] [Abstract][Full Text] [Related]
14. De novo PHF5A variants are associated with craniofacial abnormalities, developmental delay, and hypospadias.
Harms FL; Dingemans AJM; Hempel M; Pfundt R; Bierhals T; Casar C; Müller C; Niermeijer JF; Fischer J; Jahn A; Hübner C; Majore S; Agolini E; Novelli A; van der Smagt J; Ernst R; van Binsbergen E; Mancini GMS; van Slegtenhorst M; Barakat TS; Wakeling EL; Kamath A; Downie L; Pais L; White SM; de Vries BBA; Kutsche K
Genet Med; 2023 Oct; 25(10):100927. PubMed ID: 37422718
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of PHF5A Inhibits Migration and Invasion of HCC Cells via Downregulating NF-
Yang Q; Zhang J; Xu S; Jia C; Meng W; Tang H; Zhang X; Zhang Y; Fu B
Biomed Res Int; 2019; 2019():1621854. PubMed ID: 30766880
[TBL] [Abstract][Full Text] [Related]
16. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
17. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
[TBL] [Abstract][Full Text] [Related]
18. RecQ mediated genome instability 2 (
Wei W; Ying X; Chen L; Sun Q; Lu X; Xia Y; Xu R; Zhu Z; Zhang D; Tang Q; Li L; Xie J; Yu H
Aging (Albany NY); 2022 May; 14(9):4107-4136. PubMed ID: 35552266
[TBL] [Abstract][Full Text] [Related]
19. Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.
Cui Z; Zou F; Wang R; Wang L; Cheng F; Wang L; Pan R; Guan X; Zheng N; Wang W
World J Surg Oncol; 2023 Sep; 21(1):309. PubMed ID: 37759234
[TBL] [Abstract][Full Text] [Related]
20. Biological and immunological significance of DLL3 expression in different tumor tissues: a pan-cancer analysis.
Zhang Y; Shang L; Han J; Shen X; Liu H; Yang J; Shi H
Aging (Albany NY); 2023 Apr; 15(9):3427-3441. PubMed ID: 37179118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]